Anticancer agent 221
Anticancer agent 221 (Compound 4h) is an orally active anticancer agent and an antioxidant agent. Anticancer agent 221 exhibits cytotoxicity to cancer cells A549 (IC50=22.09 µg/mL) and MCF-7 (IC50=6.40 µg/mL), and induces apoptosis. Anticancer agent 221 exhibits antioxidant efficacy with an IC50 of 42.46 μM in DPPH experiment. Anticancer agent 221 exhibits antitumor efficacy against breast cancer in mouse models[1].
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-221.html
Smiles
O=C(NC1=CC2=C(C=C1)C(C=C(C(F)(F)F)O2)=O)C3=CC=C(F)C=C3
Molecular Formula
C17H9F4NO3
Molecular Weight
351.25
References & Citations
[1]Jorepalli S, et al., Synthesis, molecular docking studies and biological evaluation of N- (4-oxo-2- (trifluoromethyl) -4H-chromen-7-yl) benzamides as potential antioxidant, and anticancer agents. Sci Rep. 2024 Apr 29;14 (1) :9866.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940158-100 1x 100 µL
Cytokeratin 17 (E3), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040444-500 1x 500 µL
Pmel17 / gp100 / SILV (HMB45), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040418-500 1x 500 µL
Fascin-1 (FSCN1/418), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471815-100 1x 100 µL
Chromogranin A / CHGA (Neuroendocrine Marker) (CHGA/1815R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details